Pharmaceutical composition for treating cerebral hemorrhage

A composition and drug technology, applied in the field of medicine, can solve the problems of easy recurrence, high medical expenses, drug dependence of patients, etc., and achieve the effects of simple preparation process, high efficiency and quick treatment effect.

Inactive Publication Date: 2014-08-06
梁存福
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] For the treatment of cerebral hemorrhage, there are conventional drug therapy and surgical treatment. The effect of drug therapy is limited, and it is easy to bring side effects such as drug dependence and liver damage to patients.
However, surgical treatment is risky and expensive, and it is easy to relapse after operation, so it is not easy to choose
[0005] At present, it is believed that most patients do not need surgery when they are unconscious; if there is obvious disturbance of consciousness and brain herniation is not clear, surgical treatment is obviously better than internal medicine; surgical craniotomy has the problems of high medical expenses, serious sequelae, and high mortality. Although most of the patients saved their lives, about 90% of the patients suffered from different degrees of cranial nerve damage, causing them to be unable to take care of themselves or become vegetative

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment l

[0029] The preparation of embodiment 1 capsule

[0030] Take each raw material of the present invention by following weight parts:

[0031] 36 parts of dried bitter gourd, 24 parts of loofah, 12 parts of Alisma, 20 parts of knotweed

[0032] 36 parts of Astragalus, 12 parts of Imperata Rhizome, 12 parts of Ginkgo biloba, 8 parts of Zhuru

[0033] 30 parts of Cassia chinensis, 8 parts of Tianzhuhuang, 6 parts of Tribulus terrestris, 12 parts of licorice

[0034] The components of the above weight are dried, fully mixed, crushed into fine powder with a mesh size of 200, and packed into capsules.

Embodiment 2

[0035] The preparation of embodiment 2 granules

[0036] Take each raw material of the present invention by following weight parts:

[0037] 36 parts of dried bitter gourd, 24 parts of loofah, 12 parts of Alisma, 20 parts of knotweed

[0038] 36 parts of Astragalus, 12 parts of Imperata Rhizome, 12 parts of Ginkgo biloba, 8 parts of Zhuru

[0039] 30 parts of Cassia chinensis, 8 parts of Tianzhuhuang, 6 parts of Tribulus terrestris, 12 parts of licorice

[0040] The above-mentioned components of the above weight are dried, fully mixed, crushed into a fine powder with a mesh size of 200, and then ethanol and starch are added to prepare a granule.

Embodiment 3

[0041] The preparation of embodiment 3 capsules

[0042] Take each raw material of the present invention by following weight parts:

[0043] 30 parts of dried bitter gourd, 30 parts of loofah, 16 parts of Alisma, 36 parts of knotweed

[0044] 36 parts of Astragalus, 12 parts of Imperata Rhizome, 16 parts of Ginkgo biloba, 18 parts of Zhuru

[0045] Cassia 40 parts, Tianzhuhuang 18 parts, Tribulus terrestris 16 parts, licorice 20 parts

[0046] The components of the above weight are dried, fully mixed, crushed into fine powder with a mesh size of 200, and packed into capsules.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a traditional Chinese medicine composition for treating cerebral hemorrhage, which belongs to the technical field of medicine and consists of dried bitter gourd, loofah, Alisma, Polygonum cuspidatum, Astragalus, Imperatae, Ginkgo biloba, Zhuru, Cassia chinensis, Tianzhu Huang, Tribulus terrestris, Licorice and other traditional Chinese medicine raw materials are prepared, and all prescriptions can be used in conjunction with each other to invigorate qi and essence, replenish qi and activate blood, refresh the brain, calm liver yang, clear heat and eliminate phlegm, clear liver and wind, reduce intracranial pressure, and shrink the brain. The effect of internal hematoma, so as to achieve the effect of effective treatment of cerebral hemorrhage.

Description

technical field [0001] The invention relates to a pharmaceutical composition for treating cerebral hemorrhage, which belongs to the technical field of medicine. Background technique [0002] Cerebral hemorrhage, also known as cerebral hemorrhage, is an acute disease caused by non-traumatic rupture of cerebral arteries and blood entering the brain parenchyma. It is relatively common in acute cerebrovascular diseases. The main clinical manifestations of this disease are sudden disturbance of consciousness and limb paralysis. Usually, hypertensive patients around 50 years old suffer the most, and men are more than women. [0003] The most common cause is hypertensive cerebral hemorrhage. In consideration of other causes, high blood pressure must be effectively controlled in order to effectively avoid the occurrence of hypertensive cerebral hemorrhage. On the basis of the long-term effect of hypertension, any factor that can induce a short-term increase in blood pressure can le...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/899A61P25/00A61P9/10A61K35/56A61K35/618
Inventor 梁存福尹欣
Owner 梁存福
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products